1.932USD+8.54%Mkt Cap: 131.95M USDP/E: —Last update: 2026-05-26
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like …
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap131.95M USD
Enterprise Value76.97M USD
Revenue (TTM)525.00K USD
Gross Profit-31.09M USD
Net Income (TTM)-45.85M USD
Revenue/Share0.0080 USD
Last Price1.932 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees30
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS14147L1089
Valuation
P/E (Trailing)—
P/E (Forward)-2.18
PEG—
EV/EBITDA-1.64
EV/Revenue146.61
P/S233.11
P/B3.52
EPS (TTM)-0.67
EPS (Forward)-0.82
52W Range
1.48015% of range4.560
52W High4.560 USD
52W Low1.480 USD
Profitability
Gross Margin0.00%
Oper. Margin-31341.46%
EBITDA Margin0.00%
Profit Margin-7732.04%
ROE-101.02%
ROA-74.09%
Growth
Revenue Growth-62.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-37.92M USD
CapEx (TTM)44.00K USD
FCF Margin-3813.62%
FCF Yield-15.17%
Net Debt-45.41M USD
Net Debt/EBITDA0.96
Balance Sheet
Debt/Equity0.02
Current Ratio3.27
Quick Ratio3.20
Book Value/Sh0.5080 USD
Cash/Share0.6740 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateFeb 20, 2019
Splits
Last Split1:6
Split DateFeb 20, 2019
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)7.688 USD
Target Range2.000 USD – 12.00 USD
# Analysts8
Ownership
Shares Out.68.37M
Float66.71M
Insiders5.91%
Institutions32.86%
Short Interest
Short Ratio25.5d
Short % Float27.52%
Short % Out.26.87%
Shares Short18.37M
Short (prev mo.)17.92M
Technical
SMA 501.697 (+13.9%)
SMA 2002.096 (-7.8%)
Beta1.36
S&P 52W Chg28.31%
Avg Vol (30d)893.22K
Avg Vol (10d)1.13M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—